Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
This is a 75% increase over the number of companies inspected in the previous quarter, when four companies received four inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. Both the Drugs and Devices sectors sectors tied for second most common type.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Ambulatory Monitoring, Inc. | Devices | 02/29/2024 | Voluntary Action Indicated (VAI) |
Bedemco Import Export, Inc. | Food and Cosmetics | 03/26/2024 | No Action Indicated (NAI) |
Illycaffe Espresso USA, Inc. | Food and Cosmetics | 03/08/2024 | No Action Indicated (NAI) |
Jac Vandenberg, Inc. | Food and Cosmetics | 03/20/2024 | No Action Indicated (NAI) |
LGS Specialty Sales | Food and Cosmetics | 03/07/2024 | No Action Indicated (NAI) |
Regeneron Pharmaceuticals, Inc. | Drugs | 01/19/2024 | No Action Indicated (NAI) |
US Times Technology, Inc. | Food and Cosmetics | 01/11/2024 | Voluntary Action Indicated (VAI) |